Direct in vivo evaluation of tumor VEGFR in response to treatment with pazopanib: A novel molecular imaging study. Assessment of early vascular effects of the angiogenesis inhibitor sunitinib (SU) in ...
The risk and impact of cardiovascular (CV) adverse events (AEs) in long-term users of tyrosine kinase inhibitors (TKIs) for chronic myeloid leukaemia (CML) is highlighted in a review published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results